Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2015
Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic ReceptorsAndrew Alt, Annapurna Pendri, Robert L Bertekap, et al.Nature Communications|December 31, 2024
Grain engineering for efficient near-infrared perovskite light-emitting diodesSung-Doo Baek, Wenhao Shao, Weijie Feng, et al.Journal of Medicinal Chemistry|November 23, 2020
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionLi-Qiang Sun, Eric Mull, Stanley D'Andrea, et al.Molecular Therapy. Nucleic Acids|September 12, 2022
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathiesAmy Easton, Marianne L Jensen, Congwei Wang, et al.Journal of Medicinal Chemistry|February 26, 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infectionPaul M Scola, Li-Qiang Sun, Alan Xiangdong Wang, et al.Journal of Medicinal Chemistry|August 27, 2016
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily DosingLi-Qiang Sun, Eric Mull, Barbara Zheng, et al.Pageof 2